Stories from MedEsthetics

Business Education for Medical Practitioners
Visit us at
Thursday, January 12, 2017 - 14:18
Main Image: NEOCUTIS PREVedem Bruise Minimizing Serum helps diminish bruising and puffiness, and strengthens skin before and after cosmetic procedures. Patent-pending Hamamelis Virginiana Extract provides antioxidant support to help prepare skin for stress caused by procedures, a blend of polyphenols and essential nutrients nourish and prime skin to resist the appearance of bruising, and glycerin hydrates and soothes. Recommended use is twice daily for two weeks prior to aesthetic treatments—including injections, lasers, dermabrasion and peels—and continued application for one week...
Thursday, January 12, 2017 - 14:06
Main Image: Collagen 360 Intensive Cream from mesoestetic stimulates fibroblasts to help skin produce new collagen. Enriched marine collagen strengthens the dermal matrix to prevent degradation and smooth wrinkles; retinol evens skin tone and promotes cellular turnover; and ascorbic acid supports the extracellular matrix and provides antioxidant benefits. Contact: 818.432.9500, No, don't share this with BeautyEtcArticles: ProductsArticle free tagging: skin caremesoestetic
Thursday, January 12, 2017 - 14:01
Main Image: Environ’s Youth EssentiA Range is an antiaging skincare regimen that combines vitamins, antioxidants and peptides to create healthier, younger-looking skin. The line includes: Hydra-Intense Cleansing Lotion that removes makeup and impurities; moisturizing and antiaging Vita-Peptide Toner; fast-absorbing Vita-Peptide Eye Gel, which improves skin tone and elasticity; Antioxidant Defense Crème to hydrate and fight free radicals; and Vita Peptide C-Quence Serum, available in four levels of increasing concentrations of vitamins A, C and E.No, don't share this with...
Friday, January 6, 2017 - 11:02
Practitioners should be aware that electric microneedling device length settings do not always correspond to actual depth of penetration. For “Micro-Needling Depth Penetration, Presence of Pigment Particles, and Fluorescein-Stained Platelets: Clinical Usage for Aesthetic Concerns” (Aesthetic Surgery Journal, January 2017), Gordon H. Sasaki, MD, used excised, microneedled pre-auricular skin to determine actual depths of tissue penetration with six needle lengths.
Friday, January 6, 2017 - 11:00
Revance Therapeutics commenced a pair of double-blind, placebo-controlled, North American Phase 3 trials to evaluate single injections of drug candidate DaxibotulinumtoxinA (RT002) for the treatment of glabellar lines in about 600 total patients. The trials follow the successful BELMONT study that showed RT002 delivered six-month duration of effect, with no ptosis at the 40-unit level, in treating frown lines.
Friday, January 6, 2017 - 10:56
Allergan has received approval from the U.S. Food and Drug Administration (FDA) to market Natrelle Inspira SoftTouch breast implants, a new medium firmness, cohesive gel option for women undergoing breast reconstruction, augmentation or revision surgery.
Wednesday, January 4, 2017 - 09:19
FEATURES PDT for skin rejuvenation »A Light Boost
Thursday, December 29, 2016 - 12:08
In an article published in Plastic and Reconstructive Surgery (January 2017), Jack F. Scheuer III, MD, et al, outline general principles and safe practices for ensuring increased safety and better outcomes when administering facial filler injections. They posit that practitioners can tailor injection techniques to prevent vessel injury and avoid cannulation by considering the depth and the location of the vasculature within six “facial danger zones,” i.e., brows/glabella, temporal region, infraorbital area, lips/commissure, nasolabial folds and nose.
Thursday, December 29, 2016 - 12:03
AirXpanders has received U.S. Food and Drug Administration (FDA) de novo clearance for the AeroForm Tissue Expander System, a Class II medical device used for breast reconstruction following mastectomy. The needle-free device is activated by a handheld wireless controller that administers programmed amounts of CO2 (up to three times a day) to gradually stretch the tissue. Clinical data demonstrated that patients who used the device safely achieved full expansion in weeks (rather than months) and completed their reconstruction faster than with traditional, saline-based expanders.
Thursday, December 29, 2016 - 12:01
The U.S. Food and Drug Administration (FDA) has released a new draft guidance on the post-market management of medical device cyber security, a response to ever-evolving technology, and hence, increased risk of cyber breaches that could affect devices’ functionality throughout their life cycles. It complements an earlier final guidance issued in October 2014. This new guidance outlines steps the FDA recommends manufacturers take to continually manage cyber security risks, including:
Thursday, December 29, 2016 - 11:57
Allergan and Acelity announced that they have entered into a definitive agreement under which Allergan has agreed to acquire the regenerative medicine company LifeCell for $2.9 billion in cash, subject to customary adjustments.
Friday, December 16, 2016 - 09:38
Galderma has received U.S. Food and Drug Administration (FDA) approval of two new Restylane products for the treatment of nasolabial folds (NLF) in patients over the age of 21. Restylane Refyne is approved for the treatment of moderate to severe facial wrinkles and folds, and Restylane Defyne for the treatment of moderate to severe, deep facial wrinkles and folds.
Friday, December 16, 2016 - 09:33
A recent study, published in the Journal of Drugs in Dermatology (December 2016), evaluated the efficacy, tolerability and safety of a novel topical formulation containing high levels of physiological barrier lipids in a cholesterol-dominant ratio to address the epidermal lipid imbalances of aging skin.
Friday, December 16, 2016 - 09:15
Valeant Pharmaceuticals International announced that William D. Humphries has been appointed executive vice president, dermatology, effective January 2, 2017. He will join Valeant’s Executive Committee, reporting directly to the company’s chairman and CEO, Joseph C. Papa.
Wednesday, December 7, 2016 - 12:23
A study published online December 2, 2016, in the Aesthetic Surgery Journal sought to evaluate the impact of a plastic surgeon’s gender on patient choice.
Wednesday, December 7, 2016 - 12:06
A study published in the Journal of Drugs in Dermatology (December 2016) found that the BTL Vanquish ME (Maximum Energy) from BTL Aesthetics was effectively redesigned for more efficient and homogenous energy delivery to targeted tissue, reducing 53% more fat versus the BTL Vanquish. The BTL Vanquish ME, which debuted in 2015, is FDA-cleared for the circumferential reduction of the abdomen and thighs.
Wednesday, December 7, 2016 - 11:42
Cutera has introduced the PICO Genesis, a new nonthermal approach for the treatment of pigmentary skin concerns using the Enlighten picosecond laser system. The procedure uses ultra-short laser pulses that deliver a shockwave effect to selectively shatter pigment, and disrupt and remodel the upper dermis for a brighter, more uniform complexion. It takes about 20 minutes from start to finish, is pain-free and requires very little downtime.
Friday, December 2, 2016 - 14:51
Who is MedEsthetics for?MedEsthetics is a business resource for physicians and other professionals in the medical aesthetics industry that provides information on the latest treatments, anti-aging and medical breakthroughs, product and equipment reviews, legal issues, profiles of successful practitioners, effective marketing and management strategies, and industry news.


Advertisement - Box 1

Advertisement - Box 2

Advertisement - Box 3

Advertisement - Box 4

Advertisement - Box 5

Advertisement - Box 6